Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer.
Ontology highlight
ABSTRACT: Epithelial ovarian cancer (EOC) is the deadliest gynecologic cancer. High-grade serous carcinoma (HGSC) is the most frequently diagnosed and lethal histosubtype of EOC. A significant proportion of patients with HGSC relapse with chemoresistant disease. Therefore, there is an urgent need for novel therapeutic strategies for HGSC. Metabolic reprogramming is a hallmark of cancer cells, and targeting metabolism for cancer therapy may be beneficial. Here, we found that in comparison with normal fallopian tube epithelial cells, HGSC cells preferentially utilize glucose in the TCA cycle and not for aerobic glycolysis. This correlated with universally increased TCA cycle enzyme expression in HGSC cells under adherent conditions. HGSC disseminates as tumor cell spheroids within the peritoneal cavit
SUBMITTER: Dahl ES
PROVIDER: S-EPMC6679739 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA